Parkinsons Disease New Cure Stops Parkinsons
Scientists in the United States have discovered a drug that slows and might even stop the progression of Parkinson’s disease.
A team of researchers at Northwestern University have found in a new study that the blood pressure drug isradipine slowed down the progress of Parkinson’s disease in genetically altered lab mice, and in some cases prevented it from occurring. This is an amazing piece of the puzzle, isradipine can STOP or PREVENT Parkinsons.
Isradipine is commonly prescribed to patients to treat hypertension (high blood pressure) and to prevent a stroke.
The researchers, led by Professor D. James Surmeier, found the drug rejuvenates aging dopamine cells, whose death in the brain causes the symptoms of the disease; dopamine is a critical chemical messenger in the brain that affects a person’s ability to direct his movements.
Parkinson’s disease is fatal and there is at present no cure for it.
Dr. Surmeier says they hope the drug will protect dopamine neurons, so that if taken early enough, it will prevent Parkinson’s disease, even in those at risk.
Surmeier says isradipine could be taken in much the same way as aspirin is taken to protect the heart and might also significantly benefit people who already have Parkinson’s disease.
Surmeier’s team found that the drug protected dopamine neurons from toxins that would normally kill them by restoring the neurons to a younger state in which they are less vulnerable.
Further research plans to test the drug on humans.
Parkinson’s disease is the second leading degenerative brain disease in the United States, effecting more than 1 million people.
Dr. D. James Surmeier is the Nathan Smith Davis Professor and chair of physiology at Northwestern University’s Feinberg School of Medicine.
Stem cell treatment of Parkinson’s disease
Parkinson’s disease
Parkinson’s disease is a movement disorder and it is characterised by muscle rigidity, tremor and a slowing of physical movement. This is caused by the degenerative character of the disease, which primarily affects the central nervous system and leads to an impairment of motor and speech skills and a number of other body functions.
The Xcell-Center Parkinson’s disease treatment
The stem cells are first collected from a patient’s bone marrow, extracted from the hipbone (iliac crest) then implanted back into the body days later. Prior to re-implantation of the cells, the bone marrow is processed in one of our labs, where the quantity and quality of the stem cells is also checked.
These re-injected stem cells have the potential to transform into multiple types of cells and are capable of regenerating damaged tissue. Our innovative stem cell treatments use the self-healing potential of each patient’s own body to stimulate regeneration or repair.
11 Patients have tested this procedure
One patient reported no change in muscle spasticity, sensation, mobility or feeling of well-being after the treatment.
Two out of 11 patients reported an overall improvement, with improved mobility (legs, arms) and/or improved strength. Some patients reported a regaining of muscle strength and/or an improvement of balance. There was some improvement of speech and/or a reduction of pain and spasms.
Eight out of 11 patients reported a strong improvement, with a marked improvement of mobility, speech and significantly reduced pain and spasms.
No patients reported a perceived deterioration of the quality of their life.
There is hope!
